Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 511 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Spectrum begins SPI-2012 Phase 2 study

The multicenter, open label trial will compare SPI-2012’s effectiveness relative to a fixed and standard dose of pegfilgrastim as a simultaneous active control to each dose of SPI-2012.